InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Assets Average (2017 - 2026)

InflaRx's (IFRX) quarterly Assets Average came in at $125.6 million in Q2 2026, up 43.86% year-over-year from $87.3 million in Q2 2025, and up 106.77% quarter-over-quarter from $60.8 million in Q1 2026.

Analysis

InflaRx (IFRX) Assets Average (2017 - 2026) Analysis & Trends

InflaRx has disclosed Assets Average across 10 years of filings, most recently posting $125.6 million for Q2 2026.

  • In Q2 2026, Assets Average rose 43.86% year-over-year to $125.6 million; the TTM figure through Jun 2026 stood at $125.6 million (up 43.86% YoY), while the FY2025 annual figure was $71.8 million, down 31.8% from the prior year.
  • Assets Average came in at $125.6 million for Q2 2026 at InflaRx, up from $60.8 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $142.9 million in Q3 2023 to a low of $60.8 million in Q1 2026.
  • Average Assets Average over 5 years is $105.7 million, with a median of $108.3 million recorded in 2022.
  • Year-over-year, Assets Average plunged 37.57% in 2024 and jumped 43.86% in 2026.
  • Over 5 years, Assets Average stood at $108.3 million in 2022, then increased by 24.84% to $135.1 million in 2023, then slumped by 37.57% to $84.4 million in 2024, then dropped by 16.77% to $70.2 million in 2025, then soared by 78.89% to $125.6 million in 2026.
  • Per Business Quant data, the three most recent Assets Average figures were $125.6 million in Q2 2026, $60.8 million in Q1 2026, and $70.2 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 94.07 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 52.82 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 26.95 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 41.30 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 11.22 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 5.34 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 30.78 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 5.51 Bn
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn 125.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 125.62 Mn
Mar 31, 2026 60.76 Mn
Dec 31, 2025 70.22 Mn
Sep 30, 2025 79.65 Mn
Jun 30, 2025 87.32 Mn
Mar 31, 2025 86.37 Mn
Dec 31, 2024 84.37 Mn
Sep 30, 2024 93.85 Mn
Jun 30, 2024 108.27 Mn
Mar 31, 2024 122.84 Mn
Dec 31, 2023 135.15 Mn
Sep 30, 2023 142.87 Mn
Jun 30, 2023 118.71 Mn
Mar 31, 2023 98.56 Mn
Dec 31, 2022 108.26 Mn
Sep 30, 2022 117.18 Mn
Jun 30, 2022 125.74 Mn
Mar 31, 2022 136.16 Mn
Dec 31, 2021 147.86 Mn
Sep 30, 2021 157.59 Mn